Mahaya Clark Regenerative Health and Wellness

08/10/2020

https://youtu.be/lVJA-OiIQKs

Holistic Healing Center is in karate (Maharastra)

17/09/2020

https://youtu.be/dkLoSLhski8

Morey Blinder, MD, describes advances made in iron chelation therapy, and his personal experience with the newest version, Jadenu.

08/09/2020

https://youtu.be/qp9l5rBldVo

What is the chelation therapy? Name 3 iron chelators. Do you know their mechanism of action? Iron Cheration Therapy (2/2) https://youtu.be/BBDmSsBNQAk (Refer...

01/09/2020

In chelation therapy, you are given disodium ethylenediaminetetraacetic acid (EDTA) through a series of weekly intravenous (IV) treatments, each lasting about 30 minutes.

In general, the medication seeks out and sticks to metals and minerals in your bloodstream, creating a compound that your body removes when you urinate. Chelation therapy is promoted as a treatment for heart disease because it's thought that the medicine sticks to calcium found in fatty deposits (plaques) in the arteries.

However, chelation therapy for heart disease remains controversial. Here's what we know so far:

The Trial to Assess Chelation Therapy (TACT) didn't provide enough evidence to support routine use for heart disease. But it did find that chelation therapy offered moderate protection against future cardiovascular events, such as strokes and heart attacks, in those with diabetes. TACT2 will focus specifically on people with diabetes.
The American Heart Association and the American College of Cardiology say it's uncertain whether chelation therapy is helpful as a treatment for heart disease.
The Food and Drug Administration hasn't approved chelation therapy for use as a heart disease treatment.
Chelation therapy for heart disease has known risks and side effects. The most common is burning at the IV site. Other side effects include fever, headache, nausea or vomiting.

Rare but serious complications of chelation therapy for heart disease that have been reported include:

Abnormally low blood-calcium levels (hypocalcemia)
Sudden drop in blood pressure
Drop in bone marrow counts (bone marrow suppression)
Heart failure
Kidney damage
Death
Before trying chelation therapy as a heart disease treatment, talk to your doctor about the benefits and risks.

24/08/2020

https://theholistichealthacademy.com/why-you-definitely-have-heavy-metal-toxicity-and-what-to-do-about-it/amp/

We live in an unprecedented toxic world where heavy metals are ubiquitous – they are in our water, in our food, in our soil and in our air. Did you know that you inherit your mother’s toxic load while in the womb? This is one of the reasons generations are becoming sicker and sicker. If your pla...

20/08/2020

Vanderbilt University School of Medicine (VUSM) honored six pioneers for their historic contributions to education, science and medicine during a formal portrait unveiling at Langford Auditorium Dec. 17, 2018. The event, hosted by the Office of Diversity Affairs, was held as part of Vanderbilt Unive...

18/08/2020

https://pin.it/6qoVfJH

Discover even more ideas for you

16/08/2020

Alzheimer’s disease

The use of chelation therapy for Alzheimer’s disease is based on the belief that it’s caused by a buildup of aluminum in the brain from aluminum pots and pans, water, food, and deodorant.

However, a reviewTrusted Source of existing studies didn’t find any evidence of a relationship between exposure to aluminum and Alzheimer’s disease, though some researchersTrusted Source disagree.

Regardless of the relationship between the two, most chelators are too large to cross the blood-brain barrier. This barrier acts as a kind of net that controls what enters and exits your brain. However, some researchers believe that EDTA may be able to enter the brain, though this isn’t confirmed.

11/08/2020

The development of new therapeutic alternatives for cancers is a major public health priority. Among the more promising approaches, the iron depletion strategy based on metal chelation in the tumoral environment has been particularly studied in recent decades. After a short description of the importance of iron for cancer cell proliferation, we will review the different iron chelators developed as potential chemotherapeutics. Finally, the recent efforts to vectorize the chelating agents specifically in the microtumoral environment will be discussed in detail.

10/08/2020

Chelation therapy for heart diseases or coronary artery diseases has not proven to be effective yet. Research has pointed to the fact that EDTA binds with the calcium deposits in body and removes them. These calcium deposits sometimes hinder the flow of blood in arteries and EDTA by dissolving these deposits cleanses the arteries reducing the chances of heart problems.

EDTA the main constituent of chelation therapy is believed to have antioxidant effects as it removes the harmful metals. These metals when present in body combine with the LDL cholesterol and block the arteries. EDTA removes these metals and thus decreases the risk of diseases like atherosclerosis.

The antioxidant action of chelation therapy also shows positive results for the cure of inflammatory diseases such as lupus and scleroderma.

07/08/2020

How to do Chelation therapy and when do we need it?
When the amount of toxic metals increases in blood the person might feel symptoms like chronic fatigue syndrome, brain fog, joint or muscle pain and neurological disorders such as bad memory. These are the signs that show we need Chelation therapy to remove harmful metal toxins from our body.

In chelation therapy, a synthetic solution called EDTA (Ethylenediaminetetraacetic acid) which is a strong chelating agent is injected in body which precipitate the toxic heavy metal particles like lead, mercury, copper, aluminum, iron, calcium and arsenic from blood and helps in the cleansing of body.

However, Food and Drug Administration(FDA) has approved only the chelation therapy for the removal of toxic lead particles only and the use of chelation therapy is still controversial for other toxic metals.

04/08/2020

SOURCE, ISOLATION, AND CHARACTERIZATION OF ASCS
There are mainly two types of adipose tissue: white adipose tissue and brown adipose tissue. They are morphologically and functionally different. Brown adipose tissue much less abundant than white adipose tissue, but can be found in the neck, mediastinum, and interscapular areas in neonates. However, brown adipose tissue undergoes a morphologic transformation with aging. The appearance of brown adipose tissue is literally brown. Brown adipocytes are multilocular and retain small lipid vacuoles compared to white adipocytes. Vascularization is obvious because brown adipose tissue requires much more oxygen consumption compared to other tissues. Brown adipocytes have no known correlation with insulin resistance. The main function of brown adipose tissue is thermogenesis[12,13]. Brown adipose tissue contains a large number of mitochondria and expresses uncoupling protein 1 (UCP1). UCP1 is a brown adipose tissue-specific marker, not expressed within white adipose tissue. UCP1 is expressed in the inner membrane of mitochondria, mainly regulated by adrenergic signaling through sympathetic innervations, and this signaling is responsible for thermogenesis[12,13]. Brown adipose tissue is activated by thyroid hormone, cold temperatures, thiazolidinediones, and activated brown adipose tissue is inversely correlated with body mass index, adipose tissue mass and insulin resistance.
White adipose tissue is found throughout the body, representatively in subcutaneous and visceral adipose tissue. The appearance of white adipose tissue is yellow or ivory. White adipocytes are unilocular and contain large lipid vacuoles. White adipose tissue function is to store excess energy in the form of triglycerides, and its hyperplasia causes obesity and dysfunction of metabolic pathways as insulin resistance. UCP1 is not expressed in white adipocytes but the isoform UCP2 is expressed in parts of white adipocytes.
Recently, beige adipocytes have been discovered within white adipose tissue, especially inguinal white adipose tissue[14]. Beige adipocytes have the characteristics of both brown and white adipocytes. Beige adipocytes contain both unilocular large and multiple small lipid vacuoles. Its function is adaptive thermogenesis. In response to cold temperature exposure, beige cells transform into cells which have brown adipose tissue-like characteristics, such as UCP1 expression and small lipid vacuoles[15]. It is still controversial whether the beige adipocytes arise through the transdifferentiation of white adipocytes or by de novo adipogenesis from a subgroup of precursor cells[16,17].